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Gene Expression and RNA Splicing
The regulation of gene expression is a ubiquitous
phenomenon and is involved in virtually every process
central to an organism, ranging from the fertilization of germ
cells, across the cell cycle, to stimuli–response pathways or
apoptosis. To control the expression of genes under such
diverse contexts, regulation occurs on different cellular levels
and involves a series of complex biochemical mechanisms
that one can broadly classify into transcription, RNA
processing and cytoplasmic transport, and post-
transcriptional control and translation. While a series of
distinct machineries is involved in controlling gene
expression at each level, these complex circuits bear signs of
interconnectedness [1].
In higher eukaryotes, splicing constitutes a critical mode
for the regulation of gene expression at the level of RNA
processing [2–4]. The large majority of eukaryotic protein-
coding genes are transcribed as precursors of messenger
RNAs (pre-mRNAs), in which exons are separated from each
other by intervening regions of non-protein–coding
information (introns), which have to be correctly spliced out
to produce a mature mRNA. Splicing of pre-mRNAs occurs in
a two-step reaction (Figure 1). In the ﬁrst step, the message is
cleaved at the 59 end of an intron, and this 59 end is linked to
the branch point, which is typically in close proximity
upstream of the 39 end of the intron. In the second step, the
mRNA intermediate is cleaved at the 39 splice site (39ss), exons
are ligated, and the intron lariat is released [2]. During later
stages of spliceosome assembly, the 59ss and 39ss pair and
interact (typically across the exon, but pairing across an
intron can occur), supported by general and speciﬁc splicing
factors that recognize them. Typical mammalian genes span
tens of thousands of nucleotides, with on average nine exons
and protein-coding regions on the order of a thousand
nucleotides, thus embedding ‘‘exon islands’’ within a large
‘‘sea’’ of noncoding nucleotides that have to be accurately
recognized for correct splicing and exon ligation. This
important task is executed in the nucleus by the spliceosome,
a large ribonucleoprotein (RNP) complex that involves ﬁve
small nuclear RNAs and potentially hundreds of proteins, the
core components of which are highly conserved across
metazoan genomes [5].
Signals that specify exon–intron junctions are located at the
termini of introns. cis-Acting nucleic-acids elements are
located at the 59ss, branch point, and 39ss, and guide the
spliceosome. Almost all introns are characterized by /GT and
AG/ termini at the 5’ss and 3’ss, respectively (U2-type introns).
In addition to the canonical /GT and AG/ termini, between
four and seven nucleotides (59ss) and up to about 20
nucleotides (39ss) typically contain information for splicing. A
small fraction of U2-introns exhibits /GC–AG/ termini, while a
tiny fraction exhibits /AC–AT/ termini (U12-type introns). U2-
type and U12-type introns are spliced by distinct spliceosomes
[2]. In addition to the precise recognition of exon–intron
junctions among many possible pseudo-splice sites (that is,
intronic nucleotides matching the splice site consensus) and
the splicing of introns, the spliceosome also has to integrate
this with other steps in RNA processing, such as capping,
cleavage, and polyadenylation [6]. A picture emerges in which
the control of gene expression is in part thought of as a
network of interactions between transcription and RNA
processing, export, and transcript quality control [1].
One gene, different messages. The splicing pattern of
many pre-mRNAs is variable: different splice sites may be
used as alternatives, giving rise to multiple alternatively
spliced (AS) mRNA isoforms, and thus producing mature
mRNAs and ultimately polypeptides that can be highly
similar or markedly different while originating from the same
locus [2–4]. Detailed molecular studies of regular and disease-
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subject to AS. One powerful but not typical example of the
possibilities opened up by the process of AS is given by the D.
melanogaster gene Dscam (Figure 2), which has the potential to
produce and express hundreds to thousands of alternative
mRNA isoforms [7]. Computational analyses of available large
datasets of spliced mRNAs to genomic DNA infer that a large
number of mammalian genes (often estimated at more than
50%) produce messages that are consistent with variable
splice site choices made during alternative pre-mRNA
splicing [8,9]. In fact, the average number of detected
isoforms per gene can reach such an extent that one can
hardly distinguish the ‘‘alternative’’ transcript and might
instead invoke the concept of a set of transcripts produced
from a gene’s locus [10]. Such whole-genome bioinformatics
studies have added further lines of evidence to the
doi:10.1371/journal.pcbi.0040021.g001
Figure 1. Basic Steps of Pre-mRNA Splicing and Patterns of Alternative Exons
(A) Five small nuclear ribonucleoproteins (snRNPs U1, U2, U4, U5, and U6), an auxiliary splicing factor (U2AF), and many other factors (not represented)
organized in the human spliceosome execute the excision of introns. After the recognition of 59ss, 39ss, and branch point, respectively, by U1, U2AF, and
U2, the intron is first cleaved at the 59ss and subsequently at the 39ss, mediated by U4/U6 and U5 (U1, U2, and U4 are detached later during the cycle).
The intron remains in the nucleus and is degraded, while ligated exons are transported outside to the cytoplasm.
(B) AS events can be inferred by spliced alignments of mRNAs to genomic DNA (cf. Figure 3), indicated by dashed lines (AS part of exon colored in
black), and commonly distinguished in terms of whether mRNA isoforms differ by skipping of an exon (SE), or whether isoforms differ in the usage of a
59ss or 39ss, producing an A5E or A3E, respectively. A fourth type, termed retention-type intron, occurs when two isoforms differ by the presence of an
unspliced intron in one transcript that is spliced in the other.
(C) More complex types of AS forms can be constructed from canonical splice variants; different isoforms can also be the result of variations at the 59-
and 39-terminus of transcripts, which are not necessarily due to AS.
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be critically contributing to the diversiﬁcation of proteins
expressed in different cell types and developmental stages. As
splicing is critical to the viability of the cell, it is clear that
nonphysiological splicing decisions can have pathological
effects, and consequently splicing and AS are gaining interest
as possible explanations for human genetic disorders [11].
Figure 2 displays splice variants of known AS genes,
originating from exon-skipping, alternative 39ss exons, or
mutually exclusive exon splicing.
In addition to protein diversiﬁcation, AS might have
another function in the realm of gene regulation, by linking
splicing to a downstream control mechanism, termed
nonsense-mediated mRNA decay (NMD) [12]. Under this
scheme, aberrant or deliberately produced mRNA isoforms
that harbor shifts of the original reading-frame and hence
lead with high probability to premature termination codons
downstream of the frame shift, are candidate substrates for
NMD and shutting down of protein synthesis. While
computational studies have inferred a signiﬁcant and large
doi:10.1371/journal.pcbi.0040021.g002
Figure 2. Selection of Splice Patterns of Known Alternative Exons
Selection of splice patterns of known alternative exons of Tra, Sxl, and Dscam genes in D. melanogaster [3,4], and a-Actinin, a-Tropomyosin, Troponin-T,
and PTB in H. sapiens [71]. Exon skipping is the predominant AS event in many metazoans and, e.g., has been shown to be involved in tissue- and
developmental stage–specific regulation, as well as autoregulation (PTB) [72]. AS products of pre-mRNAs expressed from Tra and Sxl genes are involved
in the pathway of somatic sex fate in D. melanogaster, which is regulated by altogether five AS genes at the top of the determination cascade [4]. The
‘‘master gene’’ Sxl is expressed in female flies, where it acts as a negative regulator of splicing. AS of the Dscam gene is known for its theoretically large
number of possible different AS products (;38,000 against ;14,000 D. melanogaster protein-coding genes), which are derived from four clusters of
skipped exons. The regulation of one cluster includes so-called selector-docking sites, which are inverse complementary overlapping sites located in the
most 59-end intron (docking) and upstream of each skipped exon (selector) of this cluster, respectively [73].
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interrogations of splicing-sensitive micro-arrays and NMD
mutants have so far failed to detect large support for a
widespread utilization of this mechanism [14].
Computational challenges. As experimental systems and
models for the regulation of AS have been steadily validated
and reﬁned, so have bioinformatics tools and computational
models [15,16]. With the availability of complete genome
sequences and comparative genomics, the identiﬁcation of
candidate sequence elements that can be evaluated for their
activity in controlling gene expression has become a major
challenge in computational molecular biology. In order to
systematically address the level of complex control achieved
by AS, experimental and computational large-scale studies
have started to illuminate the extent, structure, and
regulatory consequences of AS and its differential usages in
mammalian genomes. Here, we focus on two selected aspects
out of a large body of computational approaches, which have
been at the center of several recent studies: starting with basic
steps for data acquisition and splice patterns classiﬁcation, we
ﬁrst present an overview and compare several methods for
candidate splicing cis-regulatory element detection.
Subsequently, we move toward the goal of predictive
identiﬁcation of AS events from genomic sequence. There are
many additional aspects of AS worth mentioning, ranging
from speciﬁc algorithms for spliced alignments to the
population genetics of exon and intron evolution, and for
these we would like to refer to additional recent excellent
reviews [4,17–20].
From Transcripts to Patterns of Alternative Splicing
The principal computational approach to identifying AS
genes, and to infer individual alternative exon events or
complete alternative isoform structures, relies on the
comparison of available transcript data to assembled
genomes and known gene loci. For this framework to work
well, one needs available complete and annotated genomes,
large collections of transcribed sequences acquired under
various cellular contexts (e.g., different cell or tissue types),
and reliable and efﬁcient algorithms for sequence alignment.
In an initial step, large-scale alignments of transcripts to
genomic DNA are conducted using a variety of systems (a
selection is listed in Table S1). The genomic sequence is
usually of high-end quality, whereas transcribed sequences
come in two different ﬂavors: 1) complementary DNAs
(cDNAs), which often produce a single or at least very limited
number of possible genomic matches; and 2) expressed
sequence tags (ESTs) or shorter reads from massively parallel
sequencing, which can produce a considerably larger number
of possible matches. ESTs are sequenced in a single pass and
are therefore available in large numbers, but often quite
error-prone especially toward the ends of a read.
At the heart of spliced-alignment algorithms are often
dynamic-programming approaches: given a transcribed
sequence (the mRNA), provide an alignment of a second
contiguous sequence (the genomic DNA) to it that is allowed
to be interrupted by long gaps which correspond to spliced-
out introns (Figure 3A). Standard gap opening/extension
penalties are not appropriate in this context; rather, gap
penalties should be based on intron length distributions, and
gaps should preferentially appear at positions that
correspond to splice sites. Practically, such an alignment is
most feasible when the contiguous sequence is restricted to
genic DNA (e.g., ENSEMBL- or similarly known annotated
genes). In the context of millions of available EST sequences,
some systems also use shortcuts to avoid the often-prohibitive
quadratic runtime complexity. The work ﬂow directing the
GENOA system [10] can serve as a practical example and is
similar to those in many databases: i) ﬁnd candidate matches
of identity between (repeat-masked ﬁltered) cDNA sequences
and genomic DNA; ii) determine spliced-alignments of
signiﬁcant matches of cDNAs to gene loci; iii) ﬁnd matches of
EST to successfully aligned cDNAs; and iv) splice-align
signiﬁcant matches of ESTs to previously cDNA-aligned gene
loci. Afterward, quality ﬁlters are typically applied, e.g., on
the number of hits of cDNAs/ESTs, percent cDNA/EST
sequence aligned and sequence identity, minimum exon and
intron sizes, maximum intron size, canonical splice sites, or
the exclusion of genes that are subject to frequent DNA
rearrangements (e.g., immunoglobulin genes).
After the genome-wide alignment, the annotation of
constitutive and alternative exons is the next step. All
transcripts aligned to a gene’s locus are scanned for AS
events, to identify alternative isoforms and which exons or
introns they affect. In this framework, constitutive exons are
the ‘‘default’’ status of exons, and this status remains unless
speciﬁed conditions for annotation as an alternative exon are
met. To this end, one can order observed splice junctions
(SJs) and their frequency of occurrence, and construct an SJ
matrix—with exons considered as ‘‘nodes’’ and SJs as ‘‘edges’’
connecting nodes. A traversal through this graph can capture
different AS patterns [21]. This scheme is exon-centric, in
that splice patterns are individually evaluated for each exon.
Individual events are commonly categorized in four
canonical patterns (Figure 1B), referred to as ‘‘skipped exon’’
(SE, or cassette exon), alternative 59ss (A5Es) or alternative
39ss exons (A3Es), or retention-type intron. These
descriptions are not necessarily exclusive, and an exon can
make several alternative splice site choices. Exon-centric
schemes can only detect canonical events, but can be
extended to capture more complex events, such as mutually
exclusive exons or clusters of skipped exons (Figure 1C). In
order to pair-wise compare isoforms generated from one
gene against one another, a possible heuristic solution is to
capture the total number of SJs that differ between two
transcripts and normalize it to the total number of SJs, within
a region where both transcripts overlap genomic DNA [22].
Storing ingoing and outgoing edges in the SJ matrix allows
for the construction of complete isoforms as a representative
path through the graph [16].
Computational analyses indicate that AS predominantly
generates SE events in both human and mouse
transcriptomes [22], and likely generally across vertebrates
[23]. The frequency of SE events is followed by A5E and A3E
events, which in turn are followed by retention-type introns,
overlapping exons (simultaneous occurrence of A5E and A3E
events), and mutually exclusive exons. When accumulating
splice variants and monitoring the respective frequency of
alternatives, one often obtains a bimodal distribution of the
percentage of events, in particular for the inclusion and
exclusion of SEs, and the two variants are in such cases
referred to as ‘‘major’’ and ‘‘minor’’ isoforms depending on
their frequency. Expectedly, the availability of a larger
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of observing alternative isoforms of that gene, so the
proportion of AS genes will tend to increase with increasing
transcript coverage of genes. Probabilistic and sampling
strategies have been discussed to circumvent or correct for
this bias [21,22,24].
Signals for Splicing Specificity and Strategies for
Their Identification
A comparison of general splicing signals (59ss, 39ss, and
branch point) between baker’s yeast, C. elegans, A. thaliana, and
humans shows that the information content of these signals is
less and less preserved with an increasing number of introns
[25,26], and in higher eukaryotes is often insufﬁcient to
ensure correct RNA splicing. The growing degeneracy, in
turn, opens up the possibility for making alternative splice
sites choices, and additional signals become necessary [27], in
particular when weak splice sites are involved [28]. It is known
that the choice of a splice site can be affected by a number of
features, including exon and ﬂanking intron size, splice site
strength, splicing regulatory elements, interspersed repeat
content, mRNA secondary structure, or RNA editing.
Splicing-speciﬁc elements function in context as exonic/
intronic splicing enhancers (ESE/ISE elements) or silencers
(ESS/ISS elements), and alter splice site choices by recruiting
positive or negative trans-acting regulatory factors (Figure
3B). All elements are more or less ubiquitous in constitutive
and alternative exons, short (;6–10 nucleotides long, with
some longer exceptions), and present in the majority of exons
or introns [29,30].
doi:10.1371/journal.pcbi.0040021.g003
Figure 3. From Sequences to Patterns and Functional Elements
(A) AS events can be computationally inferred by spliced-sequence alignments of complete or partial mRNAs to genomic DNA. A selection of available
algorithms and software is listed in Table S1. The sketch shows seven mRNAs with indicated exon junctions (for visual guidance only), the primary
transcript structures of which are to be inferred from alignments to genomic DNA (the order of the mRNAs above and below the genomic DNA is the
same). In the example shown, the set of mRNAs aligns to five exons (E1 to E5), and the data are consistent with two AS events: E2 alternative 39ss
splicing, and E3 skipping (skipped in the fourth mRNA from the top).
(B) Splicing-regulatory elements are distinguished depending on their location (exon or intron) and their mode of action (enhancing or silencing): 1)
exonic splicing enhancer (ESE) elements; 2) exonic splicing silencer (ESS) elements; 3) intronic splicing enhancer (ISE) elements; and 4) intronic splicing
silencer (ISS) elements. One can subclassify these elements whether they carry protein-coding information, act in the context of 59ss and/or 39ss, or are
sequence-conserved across species (indicated by the presence of vertical colored bars).
(C) Often, ESE, ESS, ISE, and ISS elements do not act independently of their sequence context, but can assume antagonistic functions (enhancing versus
silencing) in splicing. The color-coded example sequence elements are taken from the literature [27,28,32,38].
PLoS Computational Biology | www.ploscompbiol.org January 2008 | Volume 4 | Issue 1 | e21 0008While there is presently no validated large set of such
elements, tested in various standard splicing contexts, ESE
and ESS elements are currently the best characterized [17,31].
ESE elements often recruit arginine/serine dipeptide-rich
(SR) proteins, which themselves recruit other spliceosomal
components via protein–protein interactions. The family of
nuclear heterogeneous RNPs (hnRNPs) characterizes another
class of splicing factors that often antagonizes members of the
SR protein family and are thought to be recruited by ESS
elements. Biochemical investigations have further revealed
highly speciﬁc factors that bind to splicing regulatory
elements, including members of the CELF [32], NOVA [33,34],
PTB [35], and FOX [36] families of proteins. FOX-1, for
example, is an RNA-binding protein expressed in brain,
heart, and skeletal muscle tissues, and binds to the UGCAUG
motif [37]. Interestingly, this motif has been computationally
identiﬁed downstream of the 59ss region, by searching AS
genes speciﬁcally expressed in the human brain displaying
exon-skipping events [38].
Early indications for the role of splicing regulatory
elements were obtained, e.g., from disease-associated studies
where a chance disruption pointed to the presence of
functional sites, and often to evolutionary conservation
around sites. Subsequently, several systematic computational
and/or experimental assays have been developed to identify
ESE, ESS, and other elements, and they can be grouped into
the following main classes:
1. A functional SELEX (systematic evolution of ligands by
exponential enrichment) approach was employed to search
for ESE elements [39]. Using repeated rounds of selection, a
library of random oligonucleotides was inserted into a
minigene construct of known splicing behavior, replacing an
authentic ESE. An entire pool of constructs, each with a
different random oligonucleotide, was transcribed and
spliced to produce a pool of mRNAs. For the next round,
products of spliced mRNAs were ampliﬁed and used to
construct a new generation of minigenes, thus starting
another cycle. After several rounds, the ‘‘ﬁttest’’ sequences
with the desired splicing activity were sufﬁciently enriched
and could then be extracted by sequencing. Subsequently,
motif searches and/or multiple alignments are used to
construct scoring matrices, e.g., for ASF/SF2, SC35, SRp40, or
SRp55 [39,40].
2. A splicing reporter system was developed in [27] to
systematically screen for ESS elements. To this end, a three-
exon (E1-E3) minigene construct was designed, where ﬁrst
and last exons together encode the complete green-
ﬂuorescent protein (GFP) and the test exon (E2) is located
between E1 and E3. Two states were of interest: 1) when E2
was included into the mature transcript, the resulting protein
was not functional; 2) when E2 was skipped, E1 and E2 formed
functional GFP. Using a library of random oligonucleotides,
which were individually inserted into E2, test constructs were
transfected into cultured cells. The cells were then
automatically screened for signals of GFP-expression by
ﬂuorescent-activated cell sorting (FACS), and GFP-active cells
could then be extracted for sequencing.
3. Computational identiﬁcations of candidate splicing-
regulatory elements in exons and introns on a genome-wide
scale have been conducted, and they can be grouped into
searches for elements involving one species, or comparative
searches in genomes of related species (Table S2). RESCUE-ESE
elements [28] were identiﬁed by statistical analyses of exons,
ﬂanking intron regions, and splice site composition. Building
on the observation that ESEs can compensate for weaker 39ss
and/or 59ss of constitutive exons, ;240 human RESCUE-ESE
motifs were predicted in a large exon set, by selecting
hexamers that were enriched in exons against introns and
weak against strong splice site scores. To further validate
RESCUE-ESE–predicted motifs, a population genetics strategy
(VERIFY) was developed [41] to assess the extent of purifying
selection on functional sequences. Using a large collection of
human single-nucleotide polymorphisms (SNPs), VERIFY
estimated that about one-ﬁfth of mutations disrupting RESCUE-
ESE elements were eliminated by selection.
PESE/PESS elements (putative exonic splicing enhancers/
silencers) were similarly identiﬁed, but come with a different
ﬂavor by avoiding any potential bias resulting from codon
usage [42]. Here, the frequency of occurrences of
oligonucleotides in noncoding exons was contrasted against
pseudo-exons and 59-UTRs of intronless genes.
Oligonucleotides that were sufﬁciently overrepresented in
noncoding exons were selected as PESE elements, while
underrepresented ones were selected as PESS elements.
ESR (exonic splicing-regulatory) and ISR (intronic splicing-
regulatory) elements were identiﬁed in comparative analyses
[43,44]. To this end, the former approach used a comparison
of the frequency of expected against observed codon pairs
(hexamers), which were additionally highly conserved in the
codon wobble positions between exons of orthologous H.
sapiens and M. musculus genes. The latter approach focused on
four-way conserved oligonucleotides in 400 nucleotides long
intronic regions upstream and downstream of all ﬂanking
exons, by including the additional mammalian genomes of C.
familiaris and R. norvegicus. Statistically enriched
oligonucleotides were retained and clustered into groups
based on their conservation. A related approach to search for
regulatory elements in two nematodes, C. elegans and C.
briggsae, was used in [45].
Out of a total of 4,096 different hexamers, the above
searches predicted elements that span a range between
several hundred to more than 50% of all hexamers, some of
which overlap to a large extent. This raises the question of
how much information is already contained in these sets, and
which splicing-regulatory elements possibly remain to be
predicted. An approach to group-predicted motifs was
developed in [46], based on compositional differences
(‘‘distances’’) between elements. It inferred both ESE and ESS
(NI-ESE/NI-ESS) elements from a compendium of RESCUE-ESE, FAS-
ESS, and PESE/PESS elements, by using the sequence similarity to
known ESE and ESS hexamers and a discriminating function
to group between positive, negative, and splicing-neutral
activity. Table S3 shows an all-against-all sequence
comparison between the different sets of predicted
regulatory elements, and Dataset S1 collects all these splicing
cis-regulatory elements discussed above.
Several lines of evidence suggest that the inﬂuence of cis-
regulatory elements exerted on splice site choices is context-
dependent, and consequently the label ‘‘ESE’’ (or any other) is
correct only in so far as the context is considered. An ESE
element may well act as negative regulator of splicing in
another context, e.g., when inserted into ﬂanking intron
regions or other exons (cf. Figure 3C).
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Prediction of Alternative Splice Site Choices from
Sequence
Phylogenetic conservation of alternative splicing. The
identiﬁcation of AS events has traditionally been based on
the analysis of the diversity observed in transcribed sequence
data. As gene expression is largely condition-speciﬁc, it is
hard to predict when we will have generated and sequenced
EST libraries under sufﬁciently different conditions, and
sufﬁciently deep to arrive at a complete compendium of
transcript diversity. This brings up an additional caveat: noise
occurs both on the level of experiment as well as in the cell.
Filters imposed on EST-based AS inference help to reduce
experimental noise and eliminate unwanted contamination.
Yet, given the considerable degeneracy of sequence signals
for splicing, the machinery itself is inherently noisy and
prone to (reproducible) errors, and cellular mechanisms such
as NMD have evolved to eliminate erroneously spliced
products. As it has been provocatively put, one may be able to
observe the alternative use of any possible splice site if one
just sequences enough ESTs [47]. The question therefore is
how many AS events actually correspond to a speciﬁc
function. In any case, widespread AS may serve as
‘‘evolutionary tunneling’’ [9,48] and provide an organism with
a mechanism to quickly ‘‘explore’’ new isoforms, only few of
which eventually become functional and get ﬁxed. In a larger
context, this connects to the question of the evolution of AS
and the structure of eukaryotic genes per se [19,49].
To reduce spurious nonfunctional alternatives,
conservation was initially used as a ﬁlter. More recently the
focus of comparative genomics has shifted toward identifying
AS events that are 1) conserved with respect to orthologous
genes (‘‘alternative conserved exons’’, or ACEs); 2) only
alternatively spliced in one species; or 3) newly created
alternative exons, which are absent in orthologous genes of
other lineages (Figure 4A). Given the differences in primary
datasets and protocols for the inference of AS, it is difﬁcult to
estimate the fraction of splicing-conserved exons of
orthologous genes. Based on transcript-inferred and
predicted ACEs, the proportion of ACEs shared between H.
sapiens/M. musculus is estimated to be ;11% of all EST-derived
skipped human exons [50], while other estimates determine
about 50% or even higher levels of conservation [51,52].
Possible reasons for such differences point to a lack of
standards across different datasets and databases, and could
possibly be attributed to differences in cDNAs/ESTs,
inference of constitutive and/or alternative exons, mixing of
splice variants (in terms of alternative splice site usage, or
high- and low-frequency inclusion), orthologous gene
relationships, or stringency of comparative analyses.
Ab initio prediction of alternative splicing events. In
response to incompleteness and noise issues that come with
transcript-derived isoforms, recent years have seen a number
of approaches that aim at the direct ‘‘ab initio’’ identiﬁcation
of AS isoforms, by methods that solely rely on (comparative)
sequence information of genomic DNA alone, without
additional data such as expressed sequences or protein
information. This is possible because exons affected by AS
have different characteristics when compared to constitutive
ones. In mammals, exon-skipping is the predominant type of
AS, and sets of ACEs of orthologous human–mouse genes
could be identiﬁed and analyzed for such functional
characteristics [53]. Compared to constitutive conserved
exons, ACEs are on average shorter, have weaker splice sites,
and exhibit higher sequence-conservation of the exon body
and ﬂanking intron regions [53], lower ESE frequencies [40]
(Holste, unpublished data), fewer SNPs, and are under higher
natural selection pressure [47]. They are also more likely to
preserve the reading frame and less likely to disrupt protein
domains, are enriched in genes expressed in the brain, and in
genes involved in transcriptional regulation, RNA processing,
and development [50]. Several ‘‘non-transcript-based’’
algorithms have utilized these observations to identify new AS
isoforms, and they can be grouped into two main classes
addressing related but different problems:
1. Exon classiﬁcation algorithms take known exons as input
and classify them into ‘‘constitutive’’ or ‘‘alternative’’.
Typically, a classiﬁer is built on known examples of
constitutive and AS exons, and uses sequence features
extracted from the exon and surrounding introns. The
approaches frequently work on known pairs of orthologous
exons, as conservation features strongly contribute to the
performance of the classiﬁer. An exception is the single-
species approach of [54], which was applied to the genome of
C. elegans, and where the missing information from
conservation is arguably offset by the simpler genome
organization compared to mammals.
One of the ﬁrst such algorithms used only exon and
ﬂanking intron conservation as features to predict that a
given conserved exon was subject to any form of AS in two
species of Drosophila [55]; despite the simplicity of the
features, its speciﬁcity was more than 40%. At the same time,
the ﬁrst system to detect ACEs in the mammalian genomes
combined thresholds of exon and intron conservation with
exon size and frame conservation, and achieved a sensitivity
of ;32% with virtually no false positives [56]. The sensitivity
of these simple approaches can be dramatically improved by
using a larger set of features, e.g., the presence of
oligonucleotides corresponding to known or predicted
sequence elements, combined with solid machine learning
approaches that include the selection of signiﬁcant features
from the large set of motifs or the utilization of sparseness
priors [50,54,57,58]. The ACESCAN system, for instance,
reported an equal recognition rate (balanced sensitivity and
speciﬁcity) of ;90%, while the speciﬁcity of newly predicted
ACEs was ;70% in experimental validations [50].
2. Exon discovery algorithms take introns as input and parse
them for the presence of hitherto unknown (and thus
presumably mostly skipped) exons. This class has received
somewhat less attention; the methods are generally based on
gene ﬁnding–related approaches such as pair hidden Markov
models (e.g., in the UNCOVER system [59]), which parse a pair of
orthologous input sequences into segments with different
functions and/or patterns of conservation, such as splice sites
or coding triplets [60]. This approach has been extended to
utilize multiple alignments of several species of Drosophila
[61].
The exons in classiﬁcation algorithms are known already,
and this usually implies that the major isoform is exon
inclusion; in comparison, newly discovered exons tend to be
excluded in the majority of transcripts, which explains why
they have not yet been annotated. Figure 4B exempliﬁes the
PLoS Computational Biology | www.ploscompbiol.org January 2008 | Volume 4 | Issue 1 | e21 0010differences of the two approaches, as well as some of the
typical features used by the classiﬁers.
Current algorithms mostly deal with the case of SEs;
however, other AS types have been tackled as well. In addition
to identifying new ACEs, the UNCOVER model also allows us to
predict cases of conserved coding H. sapiens/M. musculus
retention-type introns [59]. An early approach focused on the
identiﬁcation of new partners in a mutually exclusive pair of
SEs [62]; these exons often arise from local duplications and
therefore share considerable sequence similarity. Additional
models use protein domain information to identify which
newly predicted AS isoforms, generated by exon skipping
and/or retention-type introns, would generate known protein
domains [63,64].
How much do these exons contribute to the overall
variability in gene structures? ACESCAN (an exon classiﬁcation
method) predicted ;4,000 exons to be ACEs in the human
genome [50]; UNCOVER (an exon discovery algorithm) predicted
;50 new splicing-conserved SEs in human ENCODE regions
[59] and ;8,500 exons genome-wide, which are annotated
doi:10.1371/journal.pcbi.0040021.g004
Figure 4. Conservation of AS across Species
(A) Splice patterns of exons of pairs of orthologous genes can be classified into four ‘‘pattern conservation’’ categories, demonstrated here for SE events
in H. sapiens/M. musculus: both exons are constitutively spliced (Sh,m)—known as ‘‘constitutive conserved exons’’ (CCEs); the exon of the human gene is
alternatively spliced, the mouse one constitutively (SH,m); the exon of the mouse gene is alternatively spliced, the human one constitutively (Sh,M); both
exons are alternatively spliced (SH,M)—known as ‘‘alternative conserved exons’’ (ACEs). In addition, one can define two ‘‘gain/loss’’ categories as: the
exon of the human gene is alternatively spliced, the mouse exon is absent (SH,m —); the exon of the mouse gene is alternatively spliced, the human exon is
absent (Sh —,M).
(B) AS events can be successfully predicted ab initio, that is, from genomic sequence alone. The figure refers to SEs in particular, but results for other
classes of AS events have also been described. Published approaches address one or both of two problems: exon classification and exon discovery.
Constitutive and alternative exons show different characteristics, which can be used as features for nontranscript methods. Example features include
length of the AS exon and surrounding intron; strength of the splice sites; the level of conservation in the exon and surrounding introns; and coding-
typic conservation patterns in exon sequences. In addition, some approaches utilize the occurrence of specific sequence features corresponding to
splicing regulatory elements (parts of the figure adapted from [50]).
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ACESCAN, more than 6,000 of these passed as putative AS
candidates (Ohler and Yeo, unpublished data). A similar
survey used the phyloHMM EXONIPHY to arrive at ;700 new AS
exons—an order of magnitude less, possibly due to initial
conservation requirements in several additional mammalian
species [65]. Concerning retention-type introns in coding
regions, UNCOVER predicted the surprisingly low number of
two-dozen conserved retention-type introns across H. sapiens–
M. musculus orthologous protein-coding genes. In accord with
this small number, Hiller et al. [63] identiﬁed 65 coding
retention-type introns, but with the majority involving
noncanonical splice sites not modeled in UNCOVER. A direct
comparison of transcript-derived retention-type events was
also indicative of low conservation (Nostrand, Holste, and
Burge, unpublished data). Overall, Sorek et al. estimated that
;7% of coding exons undergo some type of AS conserved
between H. sapiens and M. musculus [65]. Even if each of these
variants would affect a different gene, this identiﬁes a
considerably sized gap between EST-observed and species-
speciﬁc AS events on the one side, and conserved and
presumably functional AS events on the other side.
None of these algorithms predicts complete mRNA
isoforms; rather, they provide the building blocks of these by
identifying the parts of a gene susceptible to different
mechanisms of AS. Rare instances of ab initio gene-ﬁnding
algorithms allow for predicting several complete alternative
gene structures in the input sequence [66,67]; these
algorithms are able to enumerate possible gene structures,
but do not use information of functional splicing cis-elements
or trans-factor concentrations to arrive at AS isoforms which
are actually produced. A ‘‘splicing simulator’’ would take as
input the sequence of a pre-mRNA and be able to
automatically predict which isoforms exist and, with
additional context information such as the expression levels
of all splicing factors, how frequently they are generated.
Compared to computational gene ﬁnders, which strongly rely
on statistical properties of reading frame, coding content,
and phylogenetic conservation [67], such an approach would
only make use of the information the cell has available at the
time of splicing in the nucleus. In practice, such splicing
simulators are still in early stages of development, but
preliminary successful results have already been achieved
with approaches that combine models for splice sites
explicitly [27] or implicitly [68] with other splicing regulatory
motifs such as ESE and ESS elements.
Resources
Finally, we want to point to resources available to
researchers who wish to obtain a deeper understanding of the
transcript variability within genes of interest, and how this
variability is generated and regulated on the level of RNA
splicing.
Value-added databases. Databases for recording types of
AS have been designed and operated for some time now, and
they can be grouped into two approaches: 1) based on
searches of published research [69,70]; and 2) automated
large-scale comparisons of transcript sequences. Broadly
speaking, the ﬁrst approach emphasizes the manual curation
and focuses on the ‘‘speciﬁcity’’ of (authentic) AS events,
while computational approaches have their focus on
‘‘sensitivity’’ as well. Currently, the pipelines to annotate gene
structures in these databases (and even more so in general-
purpose genome browsers) are heavily driven by EST and
homology evidence, and do not provide information on
splicing regulatory elements or ab initio–predicted AS events
or mRNA isoforms. AS databases that begin to include such
information are becoming available and provide a more
comprehensive picture of splicing and its regulatory elements
(Table S4).
Bioinformatics software and Web servers. Several of the
systems discussed here are accessible through a Web server or
available as download for local analyses (cf. Table S5 for a
selected overview). &
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